Terms: = Lymphoma AND CCNE1, CCNE, 898, ENSG00000105173, P24864
83 results:
1. Deep learning for [
Häggström I; Leithner D; Alvén J; Campanella G; Abusamra M; Zhang H; Chhabra S; Beer L; Haug A; Salles G; Raderer M; Staber PB; Becker A; Hricak H; Fuchs TJ; Schöder H; Mayerhoefer ME
Lancet Digit Health; 2024 Feb; 6(2):e114-e125. PubMed ID: 38135556
[TBL] [Abstract] [Full Text] [Related]
2. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [
Aoki H; Miyazaki Y; Anzai T; Yokoyama K; Tsuchiya J; Shirai T; Shibata S; Sakakibara R; Mitsumura T; Honda T; Furusawa H; Okamoto T; Tateishi T; Tamaoka M; Yamamoto M; Takahashi K; Tateishi U; Yamaguchi T
Eur Radiol; 2024 Jan; 34(1):374-383. PubMed ID: 37535157
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of diagnostic efficacy of NRP-1/CD304 in hematological diseases.
Liu YJ; Li XH; Song YL; Zhou YC; Cai RZ; Chi PD
Cancer Med; 2023 May; 12(10):11284-11292. PubMed ID: 36965095
[TBL] [Abstract] [Full Text] [Related]
4.
Cui Y; Jiang Y; Deng X; Long W; Liu B; Fan W; Li Y; Zhang X
Acad Radiol; 2023 Jul; 30(7):1408-1418. PubMed ID: 36437191
[TBL] [Abstract] [Full Text] [Related]
5. Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
Shadman M; Flinn IW; Levy MY; Porter RF; Burke JM; Zafar SF; Misleh J; Kingsley EC; Yimer HA; Freeman B; Rao SS; Chaudhry A; Tumula PK; Gandhi MD; Manda S; Chen DY; By K; Xu L; Liu Y; Crescenzo R; Idoine A; Zhang X; Cohen A; Huang J; Sharman JP
Lancet Haematol; 2023 Jan; 10(1):e35-e45. PubMed ID: 36400069
[TBL] [Abstract] [Full Text] [Related]
6. Diffuse Large B-Cell Epstein-Barr Virus-Positive Primary CNS lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics.
Pons-Escoda A; García-Ruíz A; Naval-Baudin P; Grussu F; Viveros M; Vidal N; Bruna J; Plans G; Cos M; Perez-Lopez R; Majós C
AJNR Am J Neuroradiol; 2022 Nov; 43(11):1567-1574. PubMed ID: 36202547
[TBL] [Abstract] [Full Text] [Related]
7. Deep learning radiomics of dual-modality ultrasound images for hierarchical diagnosis of unexplained cervical lymphadenopathy.
Zhu Y; Meng Z; Fan X; Duan Y; Jia Y; Dong T; Wang Y; Song J; Tian J; Wang K; Nie F
BMC Med; 2022 Aug; 20(1):269. PubMed ID: 36008835
[TBL] [Abstract] [Full Text] [Related]
8. A deep learning model combining multimodal radiomics, clinical and imaging features for differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.
Xie X; Yang L; Zhao F; Wang D; Zhang H; He X; Cao X; Yi H; He X; Hou Y
Eur Radiol; 2022 Oct; 32(10):6922-6932. PubMed ID: 35674824
[TBL] [Abstract] [Full Text] [Related]
9. Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses.
Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Klemm V; Munier CML; Hoppe AC; Tea F; Pillay A; Stella AO; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J
Am J Hematol; 2023 Jan; 98(1):131-139. PubMed ID: 35607995
[TBL] [Abstract] [Full Text] [Related]
10. Machine Learning in Differentiating Gliomas from Primary CNS lymphomas: A Systematic Review, Reporting Quality, and Risk of Bias Assessment.
Cassinelli Petersen GI; Shatalov J; Verma T; Brim WR; Subramanian H; Brackett A; Bahar RC; Merkaj S; Zeevi T; Staib LH; Cui J; Omuro A; Bronen RA; Malhotra A; Aboian MS
AJNR Am J Neuroradiol; 2022 Apr; 43(4):526-533. PubMed ID: 35361577
[TBL] [Abstract] [Full Text] [Related]
11. Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell Lung Cancer in the US From 2015 to 2020.
Desai A; Scheckel C; Jensen CJ; Orme J; Williams C; Shah N; Leventakos K; Adjei AA
JAMA Netw Open; 2022 Jan; 5(1):e2144923. PubMed ID: 35076701
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of Second Primary Malignancies in Mucosa-Associated Lymphoid Tissue lymphomas: A SEER Database Interrogation.
Timilsina S; Damato A; Budhathoki N; Grossbard ML; Braunstein M
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):76-81. PubMed ID: 34493476
[TBL] [Abstract] [Full Text] [Related]
13. Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing.
Jurmeister P; Vollbrecht C; Jöhrens K; Aust D; Behnke A; Stenzinger A; Penzel R; Endris V; Schirmacher P; Fisseler-Eckhoff A; Neumann J; Kirchner T; Büttner R; Merkelbach-Bruse S; Kreipe H; Jonigk D; Jochum W; Rodriguez R; Dietel M; Horst D; Hummel M; von Laffert M
Virchows Arch; 2021 Aug; 479(2):247-255. PubMed ID: 34173019
[TBL] [Abstract] [Full Text] [Related]
14. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis.
Ocadiz-Delgado R; Lizcano-Meneses S; Trejo-Vazquez JA; Conde-Perezprina JC; Garrido-Palmas F; Alvarez-Rios E; García-Villa E; Ruiz G; Illades-Aguiar B; Leyva-Vázquez MA; García-Carrancá A; Gariglio P
APMIS; 2021 Feb; 129(2):70-79. PubMed ID: 33112434
[TBL] [Abstract] [Full Text] [Related]
15. Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With Cancer.
Hussain M; Hou Y; Watson C; Moudgil R; Shah C; Abraham J; Budd GT; Tang WHW; Finet JE; James K; Estep JD; Xu B; Hu B; Cremer P; Jellis C; Grimm RA; Greenberg N; Popovic ZB; Cho L; Desai MY; Nissen SE; Kapadia SR; Svensson LG; Griffin BP; Cheng F; Collier P
Am J Cardiol; 2020 Dec; 137():118-124. PubMed ID: 32991858
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of lung biopsies using the 2015 WHO criteria and detection of sensitizing mutations--a single-institution experience of 5032 cases.
Zeng Y; Zhu Y; Ding Y; Xu L; Zhai B; Zhang X; Ge Q; Li J; Song Q; Li X; Zhang Z
Diagn Pathol; 2020 May; 15(1):59. PubMed ID: 32429938
[TBL] [Abstract] [Full Text] [Related]
17. Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial.
Georgi TW; Kurch L; Hasenclever D; Warbey VS; Pike L; Radford J; Sabri O; Kluge R; Barrington SF
PLoS One; 2020; 15(4):e0231027. PubMed ID: 32240248
[TBL] [Abstract] [Full Text] [Related]
18. Descriptive Epidemiology of lymphoma in Northern Iran: Results from the Golestan Registry 2004-2013.
Jafari-Delouei N; Naeimi-Tabiei M; Fazel A; Ashaari M; Hatami E; Sedaghat SM; Poorabbasi M; Hasanpour-Heidari S; Ghasemi-Kebria F; Salamat F; Moghaddami A; Gholami M; Bray F; Roshandel G
Arch Iran Med; 2020 Mar; 23(3):150-154. PubMed ID: 32126782
[TBL] [Abstract] [Full Text] [Related]
19. Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.
Chuang WY; Chang ST; Yuan CT; Chang GJ; Chang H; Yeh CJ; Ueng SH; Kao HW; Wang TH; Wan YL; Shih LY; Chuang SS; Hsueh C
Am J Surg Pathol; 2020 Feb; 44(2):232-240. PubMed ID: 31688139
[TBL] [Abstract] [Full Text] [Related]
20. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.
Maggen C; Dierickx D; Lugtenburg P; Laenen A; Cardonick E; Shmakov RG; Bellido M; Cabrera-Garcia A; Gziri MM; Halaska MJ; Ottevanger PB; Van Calsteren K; O'Laughlin A; Polushkina E; Van Dam L; Avivi I; Vandenberghe P; Woei-A-Jin FJSH; Amant F;
Lancet Haematol; 2019 Nov; 6(11):e551-e561. PubMed ID: 31564649
[TBL] [Abstract] [Full Text] [Related]
[Next]
